Free shipping on all orders over $ 500

PF-6260933

Cat. No. M20578
PF-6260933 Structure
Size Price Availability Quantity
5mg USD 112  USD112 In stock
10mg USD 178  USD178 In stock
25mg USD 364  USD364 In stock
50mg USD 550  USD550 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PF-6260933 is a potent inhibitor of MAP4K4 with an IC50 of 3.7 nM, possessing excellent kinome selectivity.

Chemical Information
Molecular Weight 296.75
Formula C16H13ClN4
CAS Number 1811510-56-1
Solubility (25°C) DMSO 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Jin Yang, et al. Biomed Pharmacother. Intestinal epithelial cell-derived exosomes package microRNA-23a-3p alleviate gut damage after ischemia/reperfusion via targeting MAP4K4

[2] Gi Suk Nam, et al. Biochem Pharmacol. A new function for MAP4K4 inhibitors during platelet aggregation and platelet-mediated clot retraction

[3] Rachel J Roth Flach, et al. Nat Commun. Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis

[4] Mark Ammirati, et al. ACS Med Chem Lett. Discovery of an in Vivo Tool to Establish Proof-of-Concept for MAP4K4-Based Antidiabetic Treatment

Related MAPKAPK2/MAP3K/MAP4K Products
MAP4K4-IN-3

MAP4K4-IN-3 is a potent and selective MAP4K4 inhibitor with an IC50 of 14.9 nM in kinase assay, and an IC50 of 470 nM in cell assay.

PROTAC MLKL Degrader-1

PROTAC MLKL Degrader-1 is a PROTAC degrader of MLKL, with a Dmax >90%.

HPK1-IN-37

HPK1-IN-37 is an inhibitor of HPK1 (IC50=3.7 nM).

GNE-6893

GNE-6893 is a potent and orally active HPK1 inhibitor.

HPK1-IN-39

HPK1-IN-39 is a selective HPK1 Inhibitor (IC50: 29 nM).

  Catalog
Abmole Inhibitor Catalog




Keywords: PF-6260933 supplier, MAPKAPK2/MAP3K/MAP4K, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.